These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20232391)

  • 1. Acceptance quality checks for qualitative fecal immunochemical tests ensure screening program consistency.
    McDonald PJ; Anderson CM; Fraser CG
    Int J Cancer; 2011 Jan; 128(1):247-8; author reply 248-9. PubMed ID: 20232391
    [No Abstract]   [Full Text] [Related]  

  • 2. Colorectal cancer screening: will global warming affect the accuracy of FIT testing?
    Rennert G
    Gut; 2010 Nov; 59(11):1451-2. PubMed ID: 20947877
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
    Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
    Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical versus guaiac fecal occult blood tests.
    Technol Eval Cent Assess Program Exec Summ; 2004 Jul; 19(5):1-3. PubMed ID: 15473055
    [No Abstract]   [Full Text] [Related]  

  • 5. [Improvement in screening for colorectal cancer associated with the use of immunochemical faecal occult blood test].
    Launoy G
    Pathol Biol (Paris); 2009 Sep; 57(6):488-92. PubMed ID: 18834677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population.
    Launoy GD; Bertrand HJ; Berchi C; Talbourdet VY; Guizard AV; Bouvier VM; Caces ER
    Int J Cancer; 2005 Jun; 115(3):493-6. PubMed ID: 15700317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of several immunochemical tests for colorectal cancer.
    Nakama H; Kamijo N; Miyata K; Abdul Fattah AS; Zhang B; Uehara Y
    Hepatogastroenterology; 1998; 45(23):1579-82. PubMed ID: 9840108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advantage of immunochemical fecal occult blood test in screening for colorectal cancer].
    Launoy G; Berchi C
    Bull Cancer; 2005 Oct; 92(10):885-90. PubMed ID: 16266872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests.
    Brenner H; Haug U; Hundt S
    Int J Cancer; 2010 Oct; 127(7):1643-9. PubMed ID: 20049840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
    Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
    Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
    Nakama H; Kamijo N
    Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
    Haug U; Hundt S; Brenner H
    Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New criteria for detecting occult hemorrhage in screening for colorectal cancer].
    Ottó S
    Orv Hetil; 2001 Jul; 142(29):1541-5. PubMed ID: 11494745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Fletcher RH; Ransohoff DF; Imperiale TF
    Cancer; 2007 May; 109(9):1925-6; author reply 1926. PubMed ID: 17370313
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic accuracy of immunochemical faecal occult blood tests according to number of samples and positivity threshold.
    Guittet L; Launoy G
    J Med Screen; 2008; 15(1):48-9. PubMed ID: 18416958
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoassay-based screening for colorectal cancer. More colonoscopies performed and more cancers detected than with Haemoccult.
    Prescrire Int; 2012 Dec; 21(133):299-302. PubMed ID: 23373100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for colorectal neoplasia.
    Kronborg O
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):127-9. PubMed ID: 10363197
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of three stool tests for colorectal cancer screening.
    Greenwald B
    Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for colorectal cancer in elderly persons and possible methodologies for their screening.
    Rozen P; Shabtai EI; Liphshitz I; Barchana M
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):431-7. PubMed ID: 21448071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.